Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Myelodysplastic Syndromes 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Uveal Melanoma 1Recurrence 1Oligodendroglioma 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Gliosarcoma 1Glioma 1

Interventions

pembrolizumab 5Nivolumab 3Ipilimumab 3lenvatinib 2trametinib 1tislelizumab 1tebentafusp 1spartalizumab 1ruxolitinib 1omipalisib 1binimetinib 1belinostat 1avelumab 1Vorinostat 1Valproic Acid 1Tape Recording 1Sunitinib 1Solutions 1Practice Guidelines as Topic 1Pemetrexed 1Methods 1Melphalan 1Iodized Oil 1Health Promotion 1GSK2141795 1Ethiodized Oil 1Epilim 1Educational Status 1Diet Therapy 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Uveal Melanoma × Vorinostat × Clear all
NCT01587352 2026-04-13

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡